Methotrexate at middle and high accumulative doses might be associated with lower risk of new-onset cancers in patients with rheumatoid arthritis: a nationwide population-based cohort study. (IF: 5.35; SCIE: Q1)

Methotrexate at middle and high accumulative doses might be associated with lower risk of new-onset cancers in patients with rheumatoid arthritis: a nationwide population-based cohort study. (IF: 5.35; SCIE: Q1)

Assistant Professor    6485    albertperng@gmail.com
Year2020
Author彭武村
Author count1
Created date2021-09-11
Author order第一作者
Corresponding author
Publication year2020
Publication month12
Journal nameTherapeutic Advances in Musculoskeletal Disease (Ther Adv Musculoskelet Dis)
Publication area美國
Volume12
Issue0
Start page1
End page12
Publication type
Review system
LanguageForeign Language